首页> 美国卫生研究院文献>Bioengineering >OpenDrop: An Integrated Do-It-Yourself Platform for Personal Use of Biochips
【2h】

OpenDrop: An Integrated Do-It-Yourself Platform for Personal Use of Biochips

机译:OpenDrop:个人使用生物芯片的集成式自己动手平台

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biochips, or digital labs-on-chip, are developed with the purpose of being used by laboratory technicians or biologists in laboratories or clinics. In this article, we expand this vision with the goal of enabling everyone, regardless of their expertise, to use biochips for their own personal purposes. We developed OpenDrop, an integrated electromicrofluidic platform that allows users to develop and program their own bio-applications. We address the main challenges that users may encounter: accessibility, bio-protocol design and interaction with microfluidics. OpenDrop consists of a do-it-yourself biochip, an automated software tool with visual interface and a detailed technique for at-home operations of microfluidics. We report on two years of use of OpenDrop, released as an open-source platform. Our platform attracted a highly diverse user base with participants originating from maker communities, academia and industry. Our findings show that 47% of attempts to replicate OpenDrop were successful, the main challenge remaining the assembly of the device. In terms of usability, the users managed to operate their platforms at home and are working on designing their own bio-applications. Our work provides a step towards a future in which everyone will be able to create microfluidic devices for their personal applications, thereby democratizing parts of health care.
机译:开发生物芯片或数字芯片实验室的目的是供实验室技术员或生物学家在实验室或诊所使用。在本文中,我们扩展了这一愿景,其目标是使每个人,无论其专业知识如何,都可以将生物芯片用于其个人目的。我们开发了OpenDrop,这是一个集成的电微流体平台,允许用户开发和编程自己的生物应用程序。我们解决了用户可能遇到的主要挑战:可访问性,生物协议设计以及与微流体的交互。 OpenDrop包括一个自己动手的生物芯片,具有可视界面的自动化软件工具以及用于微流体在家操作的详细技术。我们报告了OpenDrop作为开源平台发布两年的使用情况。我们的平台吸引了高度多样化的用户群,参与者来自制造商社区,学术界和行业。我们的发现表明,复制OpenDrop的尝试中有47%成功,主要挑战仍然在于设备的组装。在可用性方面,用户设法在家中操作其平台,并正在设计自己的生物应用程序。我们的工作为未来迈出了一步,每个人都将能够为自己的个人应用创建微流体设备,从而使部分医疗保健民主化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号